<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C80D6495-9BA2-4627-9C93-034D2F62AAE7"><gtr:id>C80D6495-9BA2-4627-9C93-034D2F62AAE7</gtr:id><gtr:firstName>Hamish</gtr:firstName><gtr:surname>Fraser</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127684431"><gtr:id>FF1CF689-34BB-454E-B2A8-297A68CA2192</gtr:id><gtr:title>In vivo manipulation of angiogenesis in the female reproductive system</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127684431</gtr:grantReference><gtr:abstractText>Angiogenesis is the development of new blood vessels. Rare in the adult, angiogenesis is associated with cancers, rheumatoid arthritis, neovascular macular degeneration and psoriasis. Understanding of the process of angiogenesis and the ability to manipulate it may be a key factor in the future management of these diseases. The only sites in which intense angiogenesis routinely occurs are in the ovary and uterus of pre-menopausal women. In fact, angiogenesis is crucially important to fertility. After release of the egg, the corpus luteum produces the hormone progesterone to prepare the lining of the womb for pregnancy. Specific angiogenic growth factors and receptors are essential for hormone production and creation of a healthy endometrium receptive to the fertilised egg, and for the blood supply to nourish the early pregnancy.||Our research elucidates how angiogenesis is controlled and aims to develop new treatments to either decrease angiogenesis when it is excessive or increase it when lacking. This may be important in the treatment of many diseases and it may help us promote the reproductive health of women. It is likely that inappropriate angiogenesis is a factor in some serious pregnancy problems, endometriosis, some forms of abnormal uterine bleeding, infertility and miscarriage.</gtr:abstractText><gtr:technicalSummary>Fertility is dependent on the interplay between the corpus luteum (CL) and endometrium. Both tissues undergo marked tissue and vascular remodelling in preparation for pregnancy and co-ordinated regression in a non-conception cycle.||Our objective is to elucidate the molecular and cellular regulation of the generation of a new capillary blood network in these tissues. With respect to the CL, we described, by quantitative analysis, the course of angiogenesis and pericyte recruitment in the human and marmoset throughout the ovulatory cycle and after rescue by hCG treatment in vivo or early pregnancy. Using in situ hybridization, immunocytochemistry and quantitative RT-PCR we localised and quantified expression of a number of angiogenic factors and their receptors. An outstanding feature is the intense angiogenesis that occurs during the early luteal phase and the consistently high expression of vascular endothelial growth factor (VEGF).||To study the physiological role of VEGF in detail, we inhibited its action at four defined stages of the luteal phase in the marmoset in vivo. A potent antagonist, VEGF Trap, markedly inhibited not only the initiation of luteal angiogenesis but also the on-going process. Treatment was followed by a marked restriction in the development of a microvascular tree and associated with suppression of plasma progesterone. In the macaque, a species with menstrual cycles close to the human, VEGF Trap also suppressed plasma progesterone when given in the early luteal phase. In addition, when VEGF Trap was administered during the post angiogenic mid to late luteal phase in marmosets and macaques, plasma progesterone declined. This suggests that another function of VEGF, the regulation of vascular permeability and perfusion, may be crucial for normal function.||We are applying similar approaches to investigate the regulation of endometrial angiogenesis. Results show that endometrial angiogenesis is dependent upon oestradiol which is mediated in part via VEGF.||We are building on this knowledge and expertise with in vivo model systems to increase our understanding of vascular remodelling and angiogenic regulation and manipulation.||We are investigating ||1) the hypothesis that VEGF-induced permeability has a crucial role in luteal function, through the regulation of tight junction proteins, ||2) the use luteal angiogenesis as a model to study the physiological role of other angiogenic/permeability factors in vivo, and ||3) the molecular regulation of endometrial angiogenesis by systematically studying vascular development during non-conception, conception and manipulated cycles.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1996-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1919484</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E121ACC2-0B0F-468D-AAB6-4F9E4BEBEA30</gtr:id><gtr:title>KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a374b1205c081a27b48319b7309f0146"><gtr:id>a374b1205c081a27b48319b7309f0146</gtr:id><gtr:otherNames>Gayt?n F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>A1279073650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0D5DC00-CD84-4B7D-A838-6283350C08E3</gtr:id><gtr:title>In vitro evidence suggests activin-A may promote tissue remodeling associated with human luteolysis.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48530309e0b4b812f741d67dbb62a39f"><gtr:id>48530309e0b4b812f741d67dbb62a39f</gtr:id><gtr:otherNames>Myers M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>C288768261F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09788EAD-72A0-4B02-A2AD-B83E1381CDDB</gtr:id><gtr:title>Cell junctional proteins in the human corpus luteum: changes during the normal cycle and after HCG treatment.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a9a622668867c79fccef2d09000422b"><gtr:id>1a9a622668867c79fccef2d09000422b</gtr:id><gtr:otherNames>Groten T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>C47EFE2316E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BF5651D-18F1-4FCA-B2BA-219E51AB6E2A</gtr:id><gtr:title>SRB Reproduction, Fertility and Development Award Lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium.</gtr:title><gtr:parentPublicationTitle>Reproduction, fertility, and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f48459a95ce34dab14e23b6f158cdc1"><gtr:id>1f48459a95ce34dab14e23b6f158cdc1</gtr:id><gtr:otherNames>Fraser HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1031-3613</gtr:issn><gtr:outcomeId>5D71C2553DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F8B6158-A242-46C7-A221-2263F3CEF0AA</gtr:id><gtr:title>Temporal relationship between proliferating and apoptotic hormone-producing and endothelial cells in the equine corpus luteum.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/422787b3fca4f81f9c98c8d7f5d67cb1"><gtr:id>422787b3fca4f81f9c98c8d7f5d67cb1</gtr:id><gtr:otherNames>Aguilar J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>0210BD255A8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A7A2B99-90CF-4FA3-B23A-342459BC5632</gtr:id><gtr:title>Regulation of tight junction proteins occludin and claudin 5 in the primate ovary during the ovulatory cycle and after inhibition of vascular endothelial growth factor.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7e8a5ae66b4113b8e3ec639f9b9a8"><gtr:id>d4f7e8a5ae66b4113b8e3ec639f9b9a8</gtr:id><gtr:otherNames>Rodewald M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>468729B8FD7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0C2FAF0-54C2-4ACC-AF18-F42458F792E3</gtr:id><gtr:title>The role of vascular endothelial growth factor and estradiol in the regulation of endometrial angiogenesis and cell proliferation in the marmoset.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f48459a95ce34dab14e23b6f158cdc1"><gtr:id>1f48459a95ce34dab14e23b6f158cdc1</gtr:id><gtr:otherNames>Fraser HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>D2CAA90A612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B2B0F11-16B7-425A-8164-2672AE063F9B</gtr:id><gtr:title>Inhibition of vascular endothelial growth factor in the primate ovary up-regulates hypoxia-inducible factor-1alpha in the follicle and corpus luteum.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad3dae3f4c97b96194c70cc5b22847a0"><gtr:id>ad3dae3f4c97b96194c70cc5b22847a0</gtr:id><gtr:otherNames>Duncan WC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>55F1C74C44A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB10BE1C-BA95-4234-82DD-2C5836BF340C</gtr:id><gtr:title>Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f7e8a5ae66b4113b8e3ec639f9b9a8"><gtr:id>d4f7e8a5ae66b4113b8e3ec639f9b9a8</gtr:id><gtr:otherNames>Rodewald M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>532B06D31E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBA18780-C059-4EFD-9FA1-CB4132BCCBB9</gtr:id><gtr:title>Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer.</gtr:title><gtr:parentPublicationTitle>Gynecologic oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c83445233ffdff3599fd997db915e425"><gtr:id>c83445233ffdff3599fd997db915e425</gtr:id><gtr:otherNames>Herr D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0090-8258</gtr:issn><gtr:outcomeId>1DF80EF812E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>596D8E05-3FB0-4D79-BB1B-DD9C91DF8559</gtr:id><gtr:title>Oestrogen and progesterone receptors in the marmoset endometrium: changes during the ovulatory cycle, early pregnancy and after inhibition of vascular endothelial growth factor, GnRH or ovariectomy.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/210e0110b4d842774636d5f2a0bfda59"><gtr:id>210e0110b4d842774636d5f2a0bfda59</gtr:id><gtr:otherNames>Silvestri A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>6004A99CFFB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45BCD2EC-90C6-4942-A88F-879E4784EC90</gtr:id><gtr:title>Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c83445233ffdff3599fd997db915e425"><gtr:id>c83445233ffdff3599fd997db915e425</gtr:id><gtr:otherNames>Herr D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>8BE1DBB9D52</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3524679C-4500-4208-B5F7-EC70EEC42046</gtr:id><gtr:title>Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f48459a95ce34dab14e23b6f158cdc1"><gtr:id>1f48459a95ce34dab14e23b6f158cdc1</gtr:id><gtr:otherNames>Fraser HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>85C651AC3D8</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127684431</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>